91 related articles for article (PubMed ID: 14610350)
21. Genes differentially expressed in thyroid carcinoma identified by comparison of SAGE expression profiles.
Pauws E; Veenboer GJ; Smit JW; de Vijlder JJ; Morreau H; Ris-Stalpers C
FASEB J; 2004 Mar; 18(3):560-1. PubMed ID: 14715705
[TBL] [Abstract][Full Text] [Related]
22. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
[TBL] [Abstract][Full Text] [Related]
23. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
[TBL] [Abstract][Full Text] [Related]
24. Molecular cytogenetic investigations define a subgroup of thyroid adenomas with 2p21 breakpoints clustered to a region of less than 450 kb.
Bol S; Belge G; Rippe V; Bullerdiek J
Cytogenet Cell Genet; 2001; 95(3-4):189-91. PubMed ID: 12063398
[TBL] [Abstract][Full Text] [Related]
25. Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland.
Mazzucchelli L; Burckhardt E; Hirsiger H; Kappeler A; Laissue JA
Hum Pathol; 2000 Jul; 31(7):854-9. PubMed ID: 10923924
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of survivin expression in thyroid follicular adenoma and carcinoma.
Haghpanah V; Shooshtarizadeh P; Heshmat R; Larijani B; Tavangar SM
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):422-5. PubMed ID: 17122639
[TBL] [Abstract][Full Text] [Related]
27. Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors.
Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng WH; Svensson A; Höög A; Zedenius J; Wallin G; Lui WO; Larsson C
Int J Oncol; 2005 Jan; 26(1):141-9. PubMed ID: 15586234
[TBL] [Abstract][Full Text] [Related]
28. Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas.
Marsh DJ; Zheng Z; Zedenius J; Kremer H; Padberg GW; Larsson C; Longy M; Eng C
Cancer Res; 1997 Feb; 57(3):500-3. PubMed ID: 9012481
[TBL] [Abstract][Full Text] [Related]
29. DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors.
Jacques C; Guillotin D; Fontaine JF; Franc B; Mirebeau-Prunier D; Fleury A; Malthiery Y; Savagner F
J Clin Endocrinol Metab; 2013 May; 98(5):E981-9. PubMed ID: 23569218
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia.
Caria P; Vanni R
Cancer Genet Cytogenet; 2010 Nov; 203(1):21-9. PubMed ID: 20951315
[TBL] [Abstract][Full Text] [Related]
31. Involvement of 19q13 in follicular thyroid adenoma.
Dal Cin P; Sneyers W; Aly MS; Segers A; Ostijn F; Van Damme B; Van Den Berghe H
Cancer Genet Cytogenet; 1992 May; 60(1):99-101. PubMed ID: 1591716
[TBL] [Abstract][Full Text] [Related]
32. Pleomorphic adenoma gene 1 is expressed in cultured benign and malignant salivary gland tumor cells.
Queimado L; Lopes C; Du F; Martins C; Bowcock AM; Soares J; Lovett M
Lab Invest; 1999 May; 79(5):583-9. PubMed ID: 10334569
[TBL] [Abstract][Full Text] [Related]
33. Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene.
Colamaio M; Calì G; Sarnataro D; Borbone E; Pallante P; Decaussin-Petrucci M; Nitsch L; Croce CM; Battista S; Fusco A
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2168-78. PubMed ID: 22965940
[TBL] [Abstract][Full Text] [Related]
34. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG
J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876
[TBL] [Abstract][Full Text] [Related]
35. Genomic duplication in the 19q13.42 imprinted region identified as a new genetic cause of intrauterine growth restriction.
Petre G; Lorès P; Sartelet H; Truffot A; Poreau B; Brandeis S; Martinez G; Satre V; Harbuz R; Ray PF; Amblard F; Devillard F; Vieville G; Berger F; Jouk PS; Vaiman D; Touré A; Coutton C; Bidart M
Clin Genet; 2018 Dec; 94(6):575-580. PubMed ID: 30221343
[TBL] [Abstract][Full Text] [Related]
36. Numerical aberrations, including trisomy 22 as the sole anomaly, are recurrent in follicular thyroid adenomas.
Antonini P; Lévy N; Caillou B; Vénuat AM; Schlumberger M; Parmentier C; Bernheim A
Genes Chromosomes Cancer; 1993 Sep; 8(1):63-6. PubMed ID: 7691161
[TBL] [Abstract][Full Text] [Related]
37. Aberrant deoxyribonucleic acid methylation in human thyroid tumors.
Matsuo K; Tang SH; Zeki K; Gutman RA; Fagin JA
J Clin Endocrinol Metab; 1993 Oct; 77(4):991-5. PubMed ID: 7691865
[TBL] [Abstract][Full Text] [Related]
38. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer.
Ishigaki K; Namba H; Nakashima M; Nakayama T; Mitsutake N; Hayashi T; Maeda S; Ichinose M; Kanematsu T; Yamashita S
J Clin Endocrinol Metab; 2002 Jul; 87(7):3433-40. PubMed ID: 12107263
[TBL] [Abstract][Full Text] [Related]
39. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
40. Expression of C-ERBB2 and P65 genes and their protein products in follicular neoplasms of thyroid gland.
Czyz W; Balcerczak E; Rudowicz M; Niewiadomska H; Pasieka Z; Kuzdak K; Mirowski M
Folia Histochem Cytobiol; 2003; 41(2):91-5. PubMed ID: 12722795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
